Skip to content

Transvaginal Uterus Sling: Transuterine Mesh Procedure

Transvaginal Uterus Sling: Transuterine Mesh Procedure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061647
Enrollment
Unknown
Registered
2022-06-30
Start date
2022-06-16
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic organ prolapse

Interventions

Experimental group:Transvaginal Uterus Sling

Sponsors

Department of Urology, West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Patients with pelvic organ prolapse stage >= II according to POP-Q score and who are willing to undergo surgery; 2. Postmenopausal patients; 3. Patients with complete uterine atrophy.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of total or partial hysterectomy; 2. Patients with a history of total or partial hysterectomy of the cervix; 3. Patients with uterus-related diseases (e.g. fibroids, abnormal uterine bleeding, etc.); 4. Patients with a history of cervical radiotherapy; 5. Patients with abnormal cervical cytology; 6. Patients with a history of lower abdominal and pelvic surgery; 7. Patients with coagulation disorders; 8. Patients with severe concomitant diseases that cannot tolerate surgery.

Design outcomes

Primary

MeasureTime frame
Pelvic Organ Prolapse Quantification (POP-Q) System;Pelvic Floor Distress Inventory (PFDI-20);Complications;

Countries

China

Contacts

Public ContactHong Shen

Department of Urology, West China Hospital, Sichuan University

shen1177hx@163.com+86 18980601433

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026